Issued Patents All Time
Showing 1–14 of 14 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12234227 | Pyrazole derivatives as H4 antagonist compounds | Giles Albert Brown, Miles Stuart Congreve, Barry John Teobald, Nigel Alan Swain, Mark Pickworth +1 more | 2025-02-25 |
| 12186313 | Pyridazinone compounds and their use as DAAO inhibitors | William Farnaby, Katherine Hazel, Catrina Kerr, Natasha Kinsella, David Livermore +2 more | 2025-01-07 |
| 11999745 | Pharmaceutical compounds | Miles Stuart Congreve | 2024-06-04 |
| 11129828 | Pyridazinone compounds and their use as DAAO inhibitors | William Farnaby, Katherine Hazel, Catrina Kerr, Natasha Kinsella, David Livermore +2 more | 2021-09-28 |
| 10689373 | 1,2-substituted cyclopentanes as orexin receptor antagonists | Angela Glen, Stephanie Maine, Tatsuhiko Fujimoto, John Stephen Robinson | 2020-06-23 |
| 10463663 | Pyridazinone compounds and their use as DAAO inhibitors | William Farnaby, Katherine Hazel, Catrina Kerr, Natasha Kinsella, David Livermore +2 more | 2019-11-05 |
| 10011588 | 1,2-substituted cyclopentanes as orexin receptor antagonists | Angela Glen, Stephanie Maine, Tatsuhiko Fujimoto, John Stephen Robinson | 2018-07-03 |
| 9931340 | Pyridazinone compounds and their use as DAAO inhibitors | William Farnaby, Katherine Hazel, Catrina Kerr, Natasha Kinsella, David Livermore +2 more | 2018-04-03 |
| 9790220 | Substituted cyclopentanes, tetrahydrofuranes and pyrrolidines as orexin receptor antagonists | Angela Glen, Tatsuhiko Fujimoto, John Stephen Robinson | 2017-10-17 |
| 9750748 | Pyridazinones as DAAO enzyme inhibitors | William Farnaby, Katherine Hazel, Catrina Kerr, Natasha Kinsella, David Livermore +2 more | 2017-09-05 |
| 9493432 | Cyclopentylbenzamide derivatives and their use for the treatment of psychotic and cognitive disorders | Angela Glen, John Stephen Robinson, Tatsuhiko Fujimoto | 2016-11-15 |
| 9290456 | Pyridazinone compounds and their use as DAAO inhibitors | William Farnaby, Katherine Hazel, Catrina Kerr, Natasha Kinsella, David Livermore +2 more | 2016-03-22 |
| 9180122 | 5- or 6-substituted 3-hydroxy-2 (1 H)-pyridinones as D-amino acid oxidase (DAAO) inhibitors in therapy of diseases such as schizophrenia, cognitive disorder and pain | William Farnaby, Catrina Kerr, Natasha Kinsella, David Livermore, Kevin John Merchant +2 more | 2015-11-10 |
| 9156829 | Cycloalkyl and heterocycloalkyl compounds as orexin receptor antagonists | Angela Glen, Stephanie Maine, Tatsuhiko Fujimoto, John Stephen Robinson | 2015-10-13 |